doi: 10.1002/ardp.200700116.
Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents
Affiliations
- PMID: 18214838
- DOI: 10.1002/ardp.200700116
Item in Clipboard
Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents
Arch Pharm (Weinheim).
2008 Feb.
Abstract
A series of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues have been synthesized with high regio-selectivity by employing copper(I)-catalyzed 1,3-dipolar cycloaddition of 1-O-propargyl monosaccharides with C4beta-azido podophyllotoxin and C4beta-azido-4'-O-demethyl podophyllotoxin. All the compounds were evaluated for their anticancer activity against a panel of six human cancer cell lines. Among these, 4'-O-demethyl podophyllotoxin congeners are showing promising anticancer activity mainly against HCT-15 (colon) and DU-145 (prostate) cells.
Similar articles
-
Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents.Eur J Med Chem. 2008 Oct;43(10):2067-72. doi: 10.1016/j.ejmech.2007.09.015. Epub 2007 Sep 29. Eur J Med Chem. 2008. PMID: 17988764
-
Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.Chem Biodivers. 2008 Sep;5(9):1792-802. doi: 10.1002/cbdv.200890168. Chem Biodivers. 2008. PMID: 18816530
-
4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.Eur J Med Chem. 2011 Jun;46(6):1983-91. doi: 10.1016/j.ejmech.2011.02.016. Epub 2011 Feb 24. Eur J Med Chem. 2011. PMID: 21477899
-
Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents.Curr Pharm Des. 2005;11(13):1695-717. doi: 10.2174/1381612053764724. Curr Pharm Des. 2005. PMID: 15892669 Review.
-
Recent Advances in the Application of Podophyllotoxin Derivatives to Fight Against Multidrug-Resistant Cancer Cells.Curr Top Med Chem. 2021;21(19):1712-1724. doi: 10.2174/1568026621666210113163327. Curr Top Med Chem. 2021. PMID: 33441065 Review.
Cited by
-
Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.Med Res Rev. 2015 Jan;35(1):1-62. doi: 10.1002/med.21319. Epub 2014 May 14. Med Res Rev. 2015. PMID: 24827545 Free PMC article. Review.
-
Design, Synthesis, and Biological Evaluation of Novel Biotinylated Podophyllotoxin Derivatives as Potential Antitumor Agents.Front Chem. 2019 Jun 18;7:434. doi: 10.3389/fchem.2019.00434. eCollection 2019. Front Chem. 2019. PMID: 31281809 Free PMC article.
-
Genetic diversity and structure of Sinopodophyllum hexandrum (Royle) Ying in the Qinling Mountains, China.PLoS One. 2014 Oct 15;9(10):e110500. doi: 10.1371/journal.pone.0110500. eCollection 2014. PLoS One. 2014. PMID: 25333788 Free PMC article.
-
Synthesis and anticancer activity of glucosylated podophyllotoxin derivatives linked via 4β-triazole rings.Molecules. 2013 Nov 13;18(11):13992-4012. doi: 10.3390/molecules181113992. Molecules. 2013. PMID: 24232736 Free PMC article.
-
Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity.Drug Des Devel Ther. 2019 Oct 23;13:3683-3692. doi: 10.2147/DDDT.S215895. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31695335 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
